Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 25 results for "pfizer"

Can Enterprise Search Solutions Really Improve Organisational Efficiency?

Can Enterprise Search Solutions Really Improve Organisational ...

Enterprise Search is a method to identify the content on enterprise platforms and index it so that it is available for search and display to the authorized users of that organisation. The content can have multiple sources like a database, file systems, emails ..., 1 day ago

14 images for pfizer

DNA, 4 weeks ago
DNA, 1 month ago
Business Standard, 4 weeks ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Business Standard, 2 months ago
Business Standard, 2 months ago
Business Standard, 2 months ago
Business Standard, 4 months ago
Business Standard, 5 months ago
Business Standard

GSK backs out of $20 bn bidding race for Pfizer's consumer health-care unit

Pfizer is the world's fifth-largest player in consumer health with 2.5 percent of a market bolstered by ageing populations and growing interest in health and wellness Reuters | LONDON Last Updated at March 23, 2018 20:19 IST GlaxoSmithKline has quit the race ...
 Business Standard4 weeks ago GSK pulls out of $20 bln race for Pfizer assets  DNA4 weeks ago GlaxoSmithKline, Reckitt Benckiser in final lap for Pfizer Inc's unit  Business Standard2 months ago Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms  Reuters2 months ago
Business Standard

GSK in pole position for Pfizer unit as Reckitt Benckiser quits auction

It is possible Pfizer may receive more offers, the sources added, or it could decide against a sale Reuters | New York/ London Last Updated at March 22, 2018 22:28 IST British consumer goods group Reckitt Benckiser has pulled out of talks to buy ...
 Business Standard1 month ago
Business Standard

Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

LONDON (Reuters) - Reckitt Benckiser has no regrets about its $17 billion acquisition of Mead Johnson last year, its chief executive said, even though there are concerns it may now be too stretched to buy Pfizer's coveted consumer health business.
 Reuters1 month ago Reckitt Benckiser stands by Mead Johnson deal, despite Pfizer option  Business Standard1 month ago
Business Standard

HDFC Bank, Tech Mahindra, Pfizer hit 52-week high in weak market

HDFC Bank hit a new high of Rs 2,011 on BSE in intra-day trade, gaining 7.5% in past two weeks. SI Reporter | Mumbai Last Updated at January 31, 2018 15:26 IST HDFC Bank, Tech Mahindra, Pfizer, Ester Industries and Healthcare Global Enterprises from the S BSE ...
 Business Standard2 months ago

Pfizer in deal with Allogene to develop cancer cell therapies

(Reuters) - Pfizer Inc said on Tuesday it would take a 25 percent stake in Allogene Therapeutics to accelerate the development of CAR T cell therapies sourced from donors instead of patients.
 Reuters2 weeks ago

Pfizer's rare heart disease drug succeeds in late-stage study

(Reuters) - Pfizer Inc's experimental drug to treat a rare and fatal disease linked to heart failure reduced deaths and need for hospitalizations in a late-stage study.
 Reuters3 weeks ago FDA panel backs Pfizer's Xeljanz as bowel disease treatment  Reuters1 month ago

Pfizer's quit-smoking Chantix fails study in adolescent smokers

(Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.
 Reuters4 weeks ago

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

FRANKFURT (Reuters) - Merck KGaA and Pfizer received a setback on Thursday for their drug Bavencio, which is a late starter in the rapidly evolving field of cancer immunotherapies.
 Reuters2 months ago

Pfizer's Xtandi delays prostate cancer spread in early stage disease

(Reuters) - Use of Xtandi in early stage prostate cancer on top of standard hormone therapy reduced the risk of disease spreading or death by 71 percent compared with hormone therapy alone, study results that could lead to significantly increased sales of the ...
 Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less